What is Ventum Cap Mkts’ Estimate for MariMed Q1 Earnings?

MariMed Inc. (OTCMKTS:MRMD) – Research analysts at Ventum Cap Mkts issued their Q1 2025 EPS estimates for MariMed in a research report issued to clients and investors on Thursday, March 6th. Ventum Cap Mkts analyst A. Semple forecasts that the company will post earnings per share of ($0.01) for the quarter. Ventum Cap Mkts also issued estimates for MariMed’s Q2 2025 earnings at ($0.01) EPS, Q3 2025 earnings at $0.00 EPS and Q4 2025 earnings at $0.00 EPS.

MariMed Trading Down 2.6 %

MRMD opened at $0.10 on Monday. The firm’s fifty day moving average is $0.12 and its two-hundred day moving average is $0.14. The company has a debt-to-equity ratio of 1.01, a quick ratio of 0.73 and a current ratio of 1.55. The firm has a market cap of $39.10 million, a PE ratio of -2.56 and a beta of 2.70. MariMed has a twelve month low of $0.10 and a twelve month high of $0.34.

MariMed (OTCMKTS:MRMD) last posted its earnings results on Wednesday, March 5th. The company reported ($0.01) earnings per share for the quarter, hitting the consensus estimate of ($0.01). The company had revenue of $39.00 million for the quarter, compared to analyst estimates of $42.00 million. MariMed had a negative net margin of 10.97% and a negative return on equity of 2.75%.

About MariMed

MariMed Inc engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand.